Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study

Asia Pacific Journal of Clinical Nutrition

Volumn 22, Issue 1, 2013, Pages 150-159

  Feng, Xiang ^a,b   Tucker, Katherine L ^b,c   Parnell, Laurence D ^b   Shen, Jian ^b   Lee, Yu Chi ^b   Ordovás, José M ^b   Ling, Wen Hua ^a   Lai, Chao Qiang ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b TUFTS UNIVERSITY   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Genetic association; Insulin resistance DNA damage; IRS1; Type 2 diabetes

Indexed keywords

INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; DNA DAMAGE; ETHNOLOGY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETICS; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HISPANIC; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIOECONOMICS; UNITED STATES;

ADULT; AGED; ALLELES; BLOOD GLUCOSE; BOSTON; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; GENETIC LOCI; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; HYPERGLYCEMIA; INFLAMMATION; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84873245168     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.6133/apjcn.2013.22.1.09     Document Type: Article

References (34)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414:782-7.
2. Prudente S, Morini E, Trischitta V. Insulin signaling regulating genes: effect on T2DM and cardiovascular risk. Nat Rev Endocrinol. 2009;5:682-93.
3. Thrones AC, Huang C, Klip A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol Metab. 2006;17:72-8.
4. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R et al. Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol Cell Biol. 1996;16: 3074-84.
5. Kaburagi Y, Satoh S, Tamemoto H, Yamamoto-Honda R, Tobe K, Veki K et al. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J Biol Chem. 1997;272:25839-44.
6. Kulkarni RN, Winnay JN, Daniels M, Brüning JC, Flier SN, Hanahan D, Kahn CR. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J Clin Invest. 1999;104:R69-75.
7. Shirakami A, Toyonaga T, Tsuruzoe K, Shirotani T, Matsumoto K, Yoshizato K, et al. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J Endocrinol. 2002;174:309-19.
8. Draznin B. Molecular mechanisms of insulin resistance: serine phosphorylation of insulin receptor substrate-1 and increased expression of p857α. Diabetes. 2006;55:2392-97.
9. Florez JC, Sjögren M, Burtt N, Orho-Melander M, Schayer S, Sun M, et al. Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes. 2004; 53:3313-8.
10. Rung J, Stephane C, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proenca C, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41:1110-15.
11. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996;347:444-5.
12. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339: 1-9.
13. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34.
14. van der Horst A, Burgering BM. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol. 2007;8:440-50.
15. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2001;1:361-70.
16. Tucker KL, Mattei J, Noel SE, Collado BM, Mendez J, Nelson J, Griffith J, Ordovas JM, Falcon LM. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health. 2010; 10:107-10.
17. Almind K, Bjoraek C, Vestergaard, Hansen T, Echwald S, Pedersen O. Aminoacid polymorphism of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993;342:828-32.
18. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 2001;15:2099-111.
19. Hitman GA, Hawrami K, Mccarthy MI, Viswanathan M, Snehalatha C, Ramachandran A, Tuomilehto J, Tuomilehto-Wolf E, Nissinen A, Pedersen O. Insulin receptor substrate-1 gene mutations in NIDDM: implications for the study of polygenic disease. Diabetologia. 1995;38:481-6.
20. Lee IM, Paffenbarger RS Jr. Physical activity and stroke incidence: the Harvard Alumni Health Study. Stroke. 1998; 29:2049-54.
21. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care. 2008;31(suppl 1):S12-54.
22. Lai CQ, Tucker KL, Parnell LD, Adiconis X, García-Bailo B, Griffith J, Meydani M, Ordovás JM. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes. 2008;57:809-16.
23. de Bakker PIW, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217-23.
24. Mattei J, Parnell LD, Lai CQ, García-Bailo B, Adiconis X, Shen J, Arnett D, Demissie S, Tucker KL, Ordovas JM. Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genet. 2009;10:45-8.
25. Doerge RW, Churchill GA. Permutation tests for multiple loci affecting a quantitative character. Genetics. 1996;142: 285-94.
26. Lai CQ, Tucker KL, Choudhry S, Parnell LD, Mattei J, García-Bailo B, Beckman K, Burchard EG, Ordovás JM. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet. 2009; 125:199-209.
27. Florez JC, Sjögren M, Agapakis CM, Burtt NP, Almgren P, Lindblad U, et al. Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes. Diabetologia. 2007;50:1209-17.
28. Morini E, Prudente S, Succurro E, Chandalia M, Zhang YY, Mammarella S, et al. IRS1 G972R polymorphism and type 2 diabetes: a paradigm for the difficult ascertainment of the contribution to disease susceptibility of 'low-frequency-lowrisk' variant. Diabetologia. 2009;52:1852-7.
29. Dong XC, Copps KD, Guo S, Li Y, Kollipara R, Depinho RA, White MF. Inactivation of hepatic Foxo1 by insulwth regulation. Cell Metab. 2008;8:65-76.in signaling is required for adaptive nutrient homeostasis and endocrine gro
30. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267-73.
31. Olmos Y, Valle I, Borniquel S, Tierrez A, Soria E, Lamas S, Monsalve M. Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes. J Biol Chem. 2009;284:14476-84.
32. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-25.
33. Nandi A, Kitamura Y, Kahn CR, Accili D. Mouse models of insulin resistance. Physiol Rev. 2004;84:623-47.
34. Kubota N, Kubota T, Itoh S, Kumagai H, Kozono H, Takamoto I, et al. Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding. Cell Metab. 2008;8:49-64.